You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 18, May 10, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Protection for Human Subjects in Medical Research

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Woodward1 cites 1 study to generalize a claim that institutional review boards (IRBs) are overtaxed with protocols and spend only a cursory amount of time reviewing studies. My personal experience with 3 review boards, including 4 years of recent experience as an IRB member, goes against this. Under our current IRB rules, each study is reviewed in depth by 2 people, sometimes 3. This takes from a few minutes to an hour. At the IRB meeting, discussions of a well-constructed study without consent issues require 5 to 10 minutes. Studies with poor consent design or problems relating to their underlying science have taken over 45 minutes to resolve, often with a requirement that the investigator reply to criticisms at a later meeting. Our level of review is careful, and our IRB chair has explicitly defined our duty to protect research subjects.

Is our IRB overtaxed? This . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Challenges to Human Subject Protections in US Medical Research

JAMA. ;282():1947-1952.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.